Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
A South Carolina federal judge has denied Janssen Pharmaceuticals Inc. summary judgment on claims of failure to warn in an Invega action, finding questions of fact as to whether the company could have enhanced the drug’s warnings to warn of male breast growth in adolescents.
An investor has sued a Pennsylvania pharmaceutical company in federal court, accusing it of publicly announcing that it had developed a COVID-19 vaccine, when in fact, no such vaccine had been made.
A federal appeals panel has remanded 12 DePuy ASR hip cases filed by Spanish citizens and directed an Ohio federal judge to consider dismissing them for lack of diversity jurisdiction.
A New York woman has filed a putative class action alleging the makers of Belviq and Belviq XR knew from the early stages of research and development that the weight loss drugs pose a significantly elevated risk of cancer yet pushed them to market, selling millions of dollars’ worth.
A federal appeals panel has refused to reinstate a Zostavax vaccine action, agreeing with the trial court that the plaintiffs have not shown that their prior counsel’s failure to request discovery did not fall to a level warranting Rule 60(b)(6) relief.
The president of the American Bar Association has asked the Cybersecurity and Infrastructure Security Agency (CISA) to classify legal services as “essential” during the national COVID-19 crisis, thereby allowing attorneys to provide in-person assistance where needed.
The Food and Drug Administration has issued a warning regarding fraudulent COVID-19 tests, vaccines and treatments that have not been evaluated for safety and effectiveness, saying they might pose a danger to consumers.
The Pennsylvania Supreme Court has canceled arguments scheduled for April 21 through April 23, citing the state governor’s “increasingly restrictive remedial efforts” in response to the COVID-19 pandemic.
A Pennsylvania federal judge has ordered a bifurcated trial in a Zimmer uni-modular hip implant system action, with the first trial focused upon the statute of limitations, and the second on the merits.
The Maryland federal judge overseeing the Smith & Nephew Birmingham Hip Resurfacing multidistrict litigation docket has notified the parties that all non-emergency proceedings have been postponed for two weeks due to COVID-19 concerns.